LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 64 filers reported holding LEAP THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,524,694 | +902.4% | 7,425,570 | +1226.7% | 0.01% | +600.0% |
Q4 2022 | $251,867 | -48.9% | 559,705 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $493,000 | -23.4% | 559,705 | 0.0% | 0.00% | -25.0% |
Q2 2022 | $644,000 | -34.2% | 559,705 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $979,000 | -46.0% | 559,705 | 0.0% | 0.01% | -33.3% |
Q4 2021 | $1,813,000 | -19.2% | 559,705 | 0.0% | 0.01% | -10.0% |
Q3 2021 | $2,244,000 | +144.4% | 559,705 | 0.0% | 0.01% | +150.0% |
Q2 2021 | $918,000 | -13.6% | 559,705 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $1,063,000 | -15.6% | 559,705 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $1,259,000 | +13.6% | 559,705 | 0.0% | 0.01% | +25.0% |
Q3 2020 | $1,108,000 | -45.8% | 559,705 | -42.8% | 0.00% | -55.6% |
Q2 2020 | $2,045,000 | +32.3% | 978,454 | 0.0% | 0.01% | -10.0% |
Q1 2020 | $1,546,000 | +41.1% | 978,454 | 0.0% | 0.01% | +66.7% |
Q4 2019 | $1,096,000 | -4.3% | 978,454 | 0.0% | 0.01% | -25.0% |
Q3 2019 | $1,145,000 | – | 978,454 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 900,733 | $1,883,000 | 1.44% |
Sio Capital Management, LLC | 1,501,998 | $3,139,000 | 0.92% |
CVI Holdings, LLC | 704,900 | $1,473,000 | 0.55% |
Perceptive Advisors | 8,476,496 | $17,466,000 | 0.28% |
Artal Group S.A. | 2,974,000 | $6,216,000 | 0.17% |
SPHERA FUNDS MANAGEMENT LTD. | 880,000 | $1,839,000 | 0.17% |
DAFNA Capital Management LLC | 275,000 | $575,000 | 0.17% |
J. Goldman & Co LP | 1,018,285 | $2,128,000 | 0.13% |
MYDA Advisors LLC | 100,000 | $209,000 | 0.13% |
683 Capital Management, LLC | 526,466 | $1,100,000 | 0.09% |